Taiwan Clinical Oncology Society is hosting a seminar on early diagnosis and treatment of lung cancer on 08/26. Dr. Hua-Chien Chen, CEO of ACT Genomics, will be speaking at the seminar about the clinical application of next-generation sequencing in lung cancer management.